{"id":"vancomycin-and-tobramycin","safety":{"commonSideEffects":[{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Ototoxicity"},{"rate":null,"effect":"Red man syndrome (vancomycin)"},{"rate":null,"effect":"Infusion-related reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptidoglycan precursors, while tobramycin is an aminoglycoside that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Together, they provide broad-spectrum coverage against gram-positive and gram-negative organisms commonly encountered in major trauma and extremity injuries.","oneSentence":"Vancomycin and tobramycin are a combination of two antibiotics that work synergistically to inhibit bacterial cell wall synthesis and protein synthesis, respectively, to treat infections in trauma patients.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:55:25.039Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Infection prophylaxis and treatment in major extremity trauma"},{"name":"Polymicrobial infections in trauma patients"}]},"trialDetails":[{"nctId":"NCT06293352","phase":"NA","title":"Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-08-08","conditions":"Prosthetic-joint Infection, Knee Infection, Arthroplasty Complications","enrollment":153},{"nctId":"NCT07463339","phase":"PHASE2","title":"Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2026-05-01","conditions":"Critical Illness, Mechanical Ventilation","enrollment":70},{"nctId":"NCT05615844","phase":"PHASE3","title":"Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2023-11-05","conditions":"Open tíbia Fracture","enrollment":312},{"nctId":"NCT04872400","phase":"PHASE4","title":"Acute Application of Antibiotic Powder in Open Fracture Wounds","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-06-14","conditions":"Fractures, Open, Wounds and Injuries--Infections, Anti-Bacterial Agents","enrollment":20},{"nctId":"NCT04597008","phase":"PHASE3","title":"Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2021-05-11","conditions":"Post Operative Surgical Site Infection","enrollment":1550},{"nctId":"NCT07339215","phase":"NA","title":"Local Antibiotic Concentrations With Tissue Expanders in Breast Reconstruction","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-07-01","conditions":"Tissue Expander Based Breast Reconstruction","enrollment":100},{"nctId":"NCT05766670","phase":"PHASE3","title":"Intramedullary Calcium Sulfate Antibiotic Depot","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-04-08","conditions":"Open tíbia Fracture, Osteomyelitis Tibia, Tibial Fractures","enrollment":497},{"nctId":"NCT06383611","phase":"","title":"Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Osteal Therapeutics, Inc.","startDate":"","conditions":"Prosthetic-joint Infection","enrollment":""},{"nctId":"NCT03935828","phase":"PHASE2","title":"Effect of Topical Sinonasal Antibiotics","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2019-06","conditions":"Chronic Rhinosinusitis (Diagnosis), Antibiotic Side Effect","enrollment":""},{"nctId":"NCT05169229","phase":"PHASE2, PHASE3","title":"Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.","status":"RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2022-04-01","conditions":"Arthroplasty, Replacement, Hip, Osteoarthritis, Hip, Antibiotic Resistant Infection","enrollment":1100},{"nctId":"NCT07072923","phase":"PHASE4","title":"Antibiotic Impregnated Beads in Osteomyelitis","status":"NOT_YET_RECRUITING","sponsor":"University of Arizona","startDate":"2025-09-01","conditions":"Osteomyelitis of the Foot, Antibiotic Impregnated Beads, Osteomyelitis of Lower Extremities","enrollment":100},{"nctId":"NCT04678154","phase":"PHASE3","title":"Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT","status":"RECRUITING","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2021-05-07","conditions":"Post Operative Surgical Site Infection","enrollment":1200},{"nctId":"NCT05607030","phase":"PHASE2","title":"A Second Trial of the Abbreviated Protocol Two-Stage Exchange","status":"COMPLETED","sponsor":"Osteal Therapeutics, Inc.","startDate":"2023-01-23","conditions":"Prosthetic-joint Infection","enrollment":76},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":"Infections","enrollment":10},{"nctId":"NCT05786495","phase":"NA","title":"Short Antibiotic Treatment in High Risk Febrile Neutropenia","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-10-01","conditions":"Febrile Neutropenia","enrollment":80},{"nctId":"NCT05429671","phase":"PHASE3","title":"Antibiotic Loaded Cement After TKA","status":"COMPLETED","sponsor":"Rothman Institute Orthopaedics","startDate":"2022-06-20","conditions":"Total Knee Arthoplasty","enrollment":50},{"nctId":"NCT04662632","phase":"PHASE2","title":"Abbreviated Protocol for Two-Stage Exchange","status":"COMPLETED","sponsor":"Osteal Therapeutics, Inc.","startDate":"2021-11-01","conditions":"Prosthetic Joint Infection","enrollment":76},{"nctId":"NCT06262854","phase":"NA","title":"Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria Careggi","startDate":"2024-03-01","conditions":"Diabete Mellitus, Foot Ulcer, Osteomyelitis - Foot","enrollment":50},{"nctId":"NCT03875963","phase":"NA","title":"Antibiotic Loaded Calcium Sulfate RCT","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-01-01","conditions":"Fracture Non Union, Infection","enrollment":100},{"nctId":"NCT02497365","phase":"NA","title":"Besifloxacin in Bacterial Keratitis","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2015-09","conditions":"Bacterial Keratitis","enrollment":32},{"nctId":"NCT01431326","phase":"","title":"Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care","status":"COMPLETED","sponsor":"Daniel Benjamin","startDate":"2011-11","conditions":"Adenovirus, Anesthesia, Anxiety","enrollment":3520},{"nctId":"NCT04850313","phase":"NA","title":"Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2021-11-09","conditions":"Bacterial Corneal Ulcer","enrollment":3},{"nctId":"NCT02478710","phase":"PHASE4","title":"Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia","status":"TERMINATED","sponsor":"Wright State University","startDate":"2015-06","conditions":"Pneumonia, Ventilator-Associated","enrollment":16},{"nctId":"NCT03673956","phase":"PHASE1, PHASE2","title":"Topical Antibiotics in Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-09-26","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":19},{"nctId":"NCT03721328","phase":"PHASE2","title":"Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation","status":"COMPLETED","sponsor":"Osteal Therapeutics, Inc.","startDate":"2018-10-26","conditions":"Prosthetic Joint Infection","enrollment":15},{"nctId":"NCT05076955","phase":"EARLY_PHASE1","title":"Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy","status":"UNKNOWN","sponsor":"University of Mississippi Medical Center","startDate":"2021-03-31","conditions":"Diabetic Foot Ulcer","enrollment":100},{"nctId":"NCT04297631","phase":"PHASE4","title":"Intraarticular Antibiotic in TKA","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-02-14","conditions":"Antibotics in Cementless Knees","enrollment":20},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT03928522","phase":"PHASE4","title":"Antibiotic Elution in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-28","conditions":"Total Knee Replacement","enrollment":60},{"nctId":"NCT01373099","phase":"NA","title":"Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2011-08","conditions":"Osteoarthritis, Hip Infection, Prosthetic Joint Infection","enrollment":80},{"nctId":"NCT01373112","phase":"NA","title":"Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2011-12","conditions":"Osteoarthritis, Knee Infection, Prosthetic Joint Infection","enrollment":68},{"nctId":"NCT03308253","phase":"PHASE4","title":"Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site Infection","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2018-07-16","conditions":"Surgical Site Infection","enrollment":60},{"nctId":"NCT01570192","phase":"PHASE2","title":"Clinical Trials to Reduce the Risk of Antimicrobial Resistance","status":"TERMINATED","sponsor":"University of Florida","startDate":"2010-09","conditions":"Bacterial Pneumonia","enrollment":43},{"nctId":"NCT02107924","phase":"","title":"Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements","status":"WITHDRAWN","sponsor":"Michael Muldoon, M.D.","startDate":"2014-04","conditions":"Infection","enrollment":""},{"nctId":"NCT00707239","phase":"PHASE2","title":"Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia","status":"TERMINATED","sponsor":"Pfizer","startDate":"2008-12","conditions":"Pneumonia, Bacterial","enrollment":108},{"nctId":"NCT00035425","phase":"PHASE3","title":"Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-11","conditions":"Febrile Neutropenia","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":789,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vancomycin and Tobramycin","genericName":"Vancomycin and Tobramycin","companyName":"Major Extremity Trauma Research Consortium","companyId":"major-extremity-trauma-research-consortium","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vancomycin and tobramycin are a combination of two antibiotics that work synergistically to inhibit bacterial cell wall synthesis and protein synthesis, respectively, to treat infections in trauma patients. Used for Infection prophylaxis and treatment in major extremity trauma, Polymicrobial infections in trauma patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}